A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia (Q53351927)
scientific article
Language:
(P31) (Q13442814)
(P304) 228-235
(P433) 2
(P478) 51
(P577) Monday, February 1, 2010
(P921) (Q715347)
(Q181600)
(Q79460)
(Q29496)
(Q422248)
(P1433) (Q6534493)
(P1476) "A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia" (language: en)
(P2093) Richard R Furman
Andres Forero-Torres
Andrei Shustov
Jonathan G Drachman
(P2860) (Q27860585)
(Q35855029)
(Q44892386)
(Q34402999)
(Q46965117)
(Q28140129)
(Q46913558)
(Q51831972)
(Q40597431)
(Q46378902)
(Q35028895)
(Q40372837)
(Q35777555)
(Q55981046)
(Q46958940)
(Q34128389)
(Q47433684)
(Q33385558)
other details
description scientific article

External Links